<Anchor> The
AstraZeneca vaccine, which is expected to be available early next month, will be delayed by three weeks and the supply will be reduced.
As India temporarily suspends exports of AstraZeneca vaccine, there is some disruption in Korea's vaccine introduction schedule.
Reporter Nam Joo-hyun reports.
<Reporter>
The delayed vaccine is for 345,000 AstraZeneca vaccines through KOVAX, the International Vaccine Purchasing Organization.
It was scheduled to arrive at the beginning of next month, but it was postponed for three weeks in the third week of next month, and the volume was also reduced to 216,000 people, which was 129,000 people.
The additional 705,000 people, which were supposed to be received by the end of next month, are expected to arrive in May as soon as possible, but it is not clear whether the total volume will be available.
According to the Q2 vaccination plan, 569,000 people will need to start getting AstraZeneca vaccination by next month.
For the elderly aged 65 and over in nursing hospitals and facilities, disabled people, homeless facility users, special teachers and school health teachers, the vaccination plan may be disrupted.
[Jeongeungyeong / Disease Management Commissioner: looked like the Indian volume problem, worldwide right thing vaccine supply situation is unstable and insufficient;
our government has 22 one case of Nova backstage vaccine supply of raw materials to get a welcome justification for the quarter The contract with the European Union has been postponed due to difficulties.
The Korea Centers for Disease Control and Prevention is checking the schedule and quantity of other vaccines, including 250,000 Pfizer vaccines coming in tomorrow (31st).
On the other hand, the Ministry of Food and Drug Safety announced that it has conducted the first screening of the Janssen vaccine in the United States developed through a single vaccination method and confirmed that the expected preventive effect is at 67% level.